Immunohematological Outcome Among Adult HIV Patients Taking Highly Active Antiretroviral Therapy for at Least Six Months in Yabelo Hospital, Borana, Ethiopia

References

• Patwardhan M, Golwilkar A, Abhyankar JR, Atre M. Hematological profile of HIV positive patients. Indian J Pathol Microbiol. 2002;45(2):147‑150.
   PubMedGoogle Scholar
• Clark S. Experts predict global devastation due to HIV/AIDS. Lancet. 2002;360(9327):145. doi:10.1016/S0140-6736(02)09439-4
   PubMed Web of Science ®Google Scholar
• Stover J, Walker N, Garnett G. Can we reverse the HIV/AIDS pandemic with an expanded response. Lancet. 2002;360(9326):373–377.
   PubMed Web of Science ®Google Scholar
• Geletaw T, Tadesse MZ, Demisse AG. Hematologic abnormalities and associated factors among HIV infected children pre- and post-antiretroviral treatment, North West Ethiopia. J Blood Med. 2017;8(8):99–105. doi:10.2147/JBM.S137067
   PubMedGoogle Scholar
• World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization; 2007.
   Google Scholar
• Mathews S, Bala DS, Sharma A. Association of hematological profile of human immunodeficiency virus-positive patients with clinicoimmunologic stages of the disease. J Lab Physicians. 2013;5(1):34–37. doi:10.4103/0974-2727.115929
   PubMedGoogle Scholar
• Gifford RJ, De-oliveira T, Rambaut A. UK collaborative group on HIV drug resistance: phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. J Virol. 2007;81(23):13050–13056. doi:10.1128/JVI.00889-07
   PubMed Web of Science ®Google Scholar
• UNAIDS. AIDS epidemic Gap report; 2020.
   Google Scholar
• Choi SY, Kim I, Kim NJ, Lee S, Choi Y, Bae J. Hematological manifestations of human immunodeficiency virus infection and the effect of highly active antiretroviral therapy on cytopenia. Korean J Hematol. 2011;46(4):253–257. doi:10.5045/kjh.2011.46.4.253
   PubMedGoogle Scholar
• Enawgaw B, Alem M, Addis Z, Melku M. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar. BMC Hematol. 2014;14(1):14–18. doi:10.1186/2052-1839-14-14
   PubMedGoogle Scholar
• Lu DY, Wu HY, Yarla NS, Xu B, Ding J, Lu TR. HAART in HIV/AIDS Treatments: future Trends. Infect Disord Drug Targets. 2018;18(1):15–22. doi:10.2174/1871526517666170505122800
   PubMedGoogle Scholar
• Derbe M, Monga D, Daka D. Immunological response among HIV/AIDS patients before and after ART therapy at Zewuditu Hospital Addis Ababa, Ethiopia. Am J Res Commun. 2013;1(1):103–115.
   Google Scholar
• Tsegaye A, Desta K, Oma D, et al. Prevalence of anemia before and after initiation of antiretroviral therapy on HIV infected patients at Ras Desta Damtew Memorial Hospital, Addis Ababa, Ethiopia. RRJMHS. 2018;7(4):24–30.
   Google Scholar
• HIV status in Ethiopia. UNAIDS; 2018. Available from: https://www.unaids.org/en/regionscountries/countries/ethiopia. Accessed January, 2021.
   Google Scholar
• Huruy K, Kassu A, Mulu A, Wondie Y. Immune restoration disease and changes in CD4+ T cell count in HIV-infected patients during highly active antiretroviral therapy at Zewditu memorial hospital, Addis Ababa, Ethiopia. AIDS Res Ther. 2010;7(1):1–7. doi:10.1186/1742-6405-7-46
   PubMedGoogle Scholar
• Adane A, Desta K, Bezabih A, Gashaye A, Kassa D. HIV-associated anemia before and after initiation of antiretroviral therapy at ART Centre of Minilik II Hospital, Addis Ababa, Ethiopia. Ethiop Med J. 2012;50(1):13–21.
   PubMedGoogle Scholar
• Gedefaw L, Yemane T, Sahlemariam Z, Yilma D. Anemia and risk factors in HAART naive and HAART experienced HIV positive persons in south west Ethiopia: a comparative study. PLoS One. 2013;8(8):e72202. doi:10.1371/journal.pone.0072202
   PubMed Web of Science ®Google Scholar
• Saha D, Kini J, Subramaniam R. A study of the hematological profile of human immunodeficiency virus positive patients in coastal Indian region. Med sci. 2015;35(5):190–193.
   Google Scholar
• Qazi RA, Bashir N, Daud Y. Correlation of CD4 lymphocyte count with haemoglobin concentration in HIV infected patients at HIV treatment centre. Med sci. 2013;9(3):138–140.
   Google Scholar
• Robinson O, Obianime AW, Tamun I. Immunological and Hematological profile of HIV patients on antiretroviral therapy in port harcourt, River state Nigeria. Int Blood Res. 2017;7(4):1–12.
   Google Scholar
• Addis Z, Yitagezu G. Tacheble B. prevalence of some hematological abnormalities among HIV positive patients on their first visit to tertiary health institution. Int Blood Res. 2014;2(6):270–277. doi:10.9734/IBRR/2014/11137
   Google Scholar
• Woldeamanuel G, Wondimu H. Prevalence of anaemia before and after initiation of antiretroviral therapy among HIV infected Patients at black lion specialized hospital Addis Ababa, Ethiopia. BMC Hematol. 2018;18:7. doi:10.1186/s12878-018-0099-y
   PubMedGoogle Scholar
• Fenetahun Y, Fentahun T. Socio-economic profile of arid and semi-arid agro-pastoral region of Borana rangeland Southern Ethiopia. MOJ Eco Environ Sci. 2020;5(3):113–122.
   Google Scholar
• Negesse A, Getaneh T, Temesgen H. Prevalence of anemia and its associated factors in human immuno deficiency virus infected adult individuals in Ethiopia. A systematic review and meta-analysis. BMC Hematol. 2018;8:32. doi:10.1186/s12878-018-0127-y
   Google Scholar
• Assefa M, Abegaz WE, Shewamare A, Medhin G, Belay M. Prevalence and correlates of anemia among HIV infected patients on highly active antiretroviral therapy at Zewditu Memorial Hospital, Ethiopia. BMC Hematol. 2015;15(1):1–6. doi:10.1186/s12878-015-0024-6
   PubMedGoogle Scholar
• Daka D, Lelissa D, Amsalu A. Prevalence of anemia before and after the initiation of antiretroviral therapy at ART center of Hawassa University Referral Hospital, Hawassa, South Ethiopia. Sch J Med. 2013;3(1):1–6.
   Google Scholar
• Damtie S, Lemma W, Teklehaimanot K, Tahir E, Tegenaw T. Hematological abnormalities of adult HIV-infected patients before and after initiation of highly active antiretroviral treatment at Debre Tabor Comprehensive Specialized Hospital, Northcentral Ethiopia: a Cross-Sectional Study. HIV/AIDS Res Palliat Care. 2021;4(13):477–484.
   Google Scholar
• Uguma N, Kiya GT, Maleko WA, Bimerew LG. Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, South-East Ethiopia. SAGE Open Med. 2021;9:1–12.
   Google Scholar
• Denue BA, Kida IM, Hammagabdo A, Dayar A, Sahabi MA. Prevalence of anemia and immunological markers in HIV-infected patients on highly active antiretroviral therapy in Northeastern Nigeria. Infect Dis Res Treat. 2013;6:25–33.
   Google Scholar
• Owiredu WK, Quaye L, Amidu N, Addai-Mensah O. Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011;11(1):2–15.
   PubMed Web of Science ®Google Scholar